News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
252,091 Results
Type
Article (14676)
Company Profile (82)
Press Release (237333)
Multimedia
Podcasts (11)
Webinars (5)
Section
Business (75931)
Career Advice (550)
Deals (13722)
Drug Delivery (46)
Drug Development (44613)
Employer Resources (67)
FDA (5940)
Job Trends (5906)
News (137541)
Policy (11036)
Tag
Academia (1251)
Academic (1)
Accelerated approval (4)
Adcomms (5)
Allergies (61)
Alliances (19415)
ALS (55)
Alzheimer's disease (720)
Antibody-drug conjugate (ADC) (53)
Approvals (5967)
Artificial intelligence (95)
Autoimmune disease (9)
Automation (4)
Bankruptcy (127)
Best Places to Work (4867)
BIOSECURE Act (9)
Biosimilars (31)
Biotechnology (63)
Bladder cancer (44)
Brain cancer (15)
Breast cancer (150)
Cancer (1201)
Cardiovascular disease (90)
Career advice (458)
Career pathing (14)
CAR-T (85)
Cell therapy (235)
Cervical cancer (12)
Clinical research (37477)
Collaboration (405)
Compensation (111)
Complete response letters (7)
COVID-19 (1434)
CRISPR (20)
C-suite (118)
Cystic fibrosis (57)
Data (1291)
Decentralized trials (1)
Denatured (8)
Depression (17)
Diabetes (135)
Diagnostics (2349)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (27)
Drug discovery (58)
Drug pricing (40)
Drug shortages (5)
Duchenne muscular dystrophy (45)
Earnings (31837)
Editorial (13)
Employer branding (9)
Employer resources (58)
Events (30289)
Executive appointments (355)
FDA (6592)
Frontotemporal dementia (6)
Funding (399)
Gene editing (53)
Generative AI (9)
Gene therapy (151)
GLP-1 (294)
Government (1788)
Grass and pollen (3)
Guidances (36)
Healthcare (7135)
Huntington's disease (12)
IgA nephropathy (14)
Immunology and inflammation (48)
Indications (17)
Infectious disease (1493)
Inflammatory bowel disease (69)
Inflation Reduction Act (5)
Influenza (35)
Intellectual property (45)
Interviews (103)
IPO (8414)
IRA (20)
Job creations (1270)
Job search strategy (377)
Kidney cancer (8)
Labor market (13)
Layoffs (260)
Leadership (11)
Legal (2007)
Liver cancer (40)
Lung cancer (172)
Lymphoma (86)
Machine learning (3)
Management (15)
Manufacturing (124)
MASH (30)
Medical device (4677)
Medtech (4678)
Mergers & acquisitions (5599)
Metabolic disorders (325)
Multiple sclerosis (53)
NASH (7)
Neurodegenerative disease (50)
Neuropsychiatric disorders (4)
Neuroscience (992)
NextGen: Class of 2025 (2338)
Non-profit (2204)
Now hiring (10)
Obesity (169)
Opinion (82)
Ovarian cancer (46)
Pain (43)
Pancreatic cancer (57)
Parkinson's disease (73)
Partnered (12)
Patents (88)
Patient recruitment (74)
Peanut (37)
People (21384)
Pharmaceutical (21)
Pharmacy benefit managers (2)
Phase I (13026)
Phase II (16729)
Phase III (11500)
Pipeline (819)
Policy (56)
Postmarket research (1021)
Preclinical (3878)
Press Release (31)
Prostate cancer (59)
Psychedelics (7)
Radiopharmaceuticals (120)
Rare diseases (199)
Real estate (2025)
Recruiting (24)
Regulatory (8201)
Reports (24)
Research institute (1231)
Resumes & cover letters (88)
Rett syndrome (5)
RNA editing (4)
RSV (13)
Schizophrenia (28)
Series A (62)
Series B (42)
Service/supplier (3)
Sickle cell disease (27)
Special edition (4)
Spinal muscular atrophy (96)
Sponsored (14)
Startups (1672)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (13)
The Weekly (3)
Vaccines (316)
Venture capitalists (17)
Weight loss (79)
Women's health (19)
Worklife (3)
Date
Today (75)
Last 7 days (363)
Last 30 days (1152)
Last 365 days (15441)
2025 (5023)
2024 (16228)
2023 (18167)
2022 (22747)
2021 (23989)
2020 (22214)
2019 (17955)
2018 (13681)
2017 (13230)
2016 (11620)
2015 (14004)
2014 (10065)
2013 (7545)
2012 (7669)
2011 (8088)
2010 (7099)
Location
Africa (284)
Alabama (23)
Alaska (4)
Arizona (40)
Arkansas (4)
Asia (15093)
Australia (2884)
California (2752)
Canada (758)
China (225)
Colorado (120)
Connecticut (129)
Delaware (78)
Europe (32911)
Florida (412)
Georgia (105)
Idaho (15)
Illinois (181)
India (11)
Indiana (131)
Iowa (2)
Japan (92)
Kansas (72)
Kentucky (7)
Louisiana (7)
Maine (19)
Maryland (344)
Massachusetts (2589)
Michigan (84)
Minnesota (157)
Mississippi (2)
Missouri (33)
Montana (14)
Nebraska (7)
Nevada (34)
New Hampshire (26)
New Jersey (854)
New Mexico (12)
New York (917)
North Carolina (442)
North Dakota (3)
Northern California (1273)
Ohio (62)
Oklahoma (2)
Oregon (16)
Pennsylvania (601)
Puerto Rico (8)
Rhode Island (17)
South America (355)
South Carolina (5)
South Dakota (1)
Southern California (1001)
Tennessee (29)
Texas (386)
United States (10870)
Utah (73)
Virginia (79)
Washington D.C. (30)
Washington State (288)
West Virginia (2)
Wisconsin (17)
252,091 Results for "massachusetts biomedical initiatives".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
9 Companies Hiring in Massachusetts
Looking for a biopharma job in Massachusetts? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
April 17, 2025
·
2 min read
·
Angela Gabriel
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital
March 26, 2025
·
4 min read
Press Releases
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital
February 26, 2025
·
5 min read
Press Releases
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital
March 19, 2025
·
5 min read
Job Creations
Massachusetts Increases Life Sciences Investment by $500M Over 10 Years
Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.
November 21, 2024
·
2 min read
·
Angela Gabriel
Press Releases
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
March 4, 2025
·
5 min read
Psychedelics
Massachusetts Bid to Legalize Certain Psychedelic Drugs Fails
Massachusetts residents voted Tuesday against the Natural Psychedelic Substances Act, which would have seen some psychedelics, including psilocybin and dimethyltryptamine, legalized in the state.
October 21, 2024
·
7 min read
·
Heather McKenzie
Press Releases
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital
March 11, 2025
·
6 min read
Press Releases
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
December 20, 2024
·
4 min read
1 of 25,210
Next
